Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Hong Kong ETF

23.24
-0.1100-0.47%
Post-market: 23.240.00000.00%17:31 EDT
Volume:2.35M
Turnover:54.67M
Market Cap:1.28B
PE:15.90
High:23.27
Open:23.20
Low:23.18
Close:23.35
52wk High:24.66
52wk Low:20.60
Shares:54.90M
Float Shares:54.90M
Volume Ratio:1.02
T/O Rate:4.29%
Dividend:1.04
Dividend Rate:4.46%
EPS(TTM):1.46
EPS(LYR):5.66
ROE:34.64%
ROA:2.14%
PB:1.64
PE(LYR):4.10

Loading ...

GBG HOLDINGS Chair and CEO Expands Stake with Latest Share Purchase

Stock News
·
Aug 21

Starjoy W&T Stake Raised by Song Haodong to 12%

Stock News
·
Aug 21

K CASH Announces Interim Dividend Payout Scheduled for October

Stock News
·
Aug 21

Wing Tai Properties Announces Interim Dividend Payment Date

Stock News
·
Aug 21

KANGLI INT HLDG Schedules Interim Dividend Payout for September

Stock News
·
Aug 21

RAYMOND IND Sets October Payout for Interim Dividend

Stock News
·
Aug 21

CTIHK Sets September 25 Payout for Interim Dividend of HK$0.19 Per Share

Stock News
·
Aug 21

INGENIC Sets H-Share Offering Price at HK$100 Per Share

Stock News
·
Aug 21

Goldman Sachs Raises CSPC Pharma Price Target to HK$12.56, Reaffirms Buy Rating

Stock News
·
Aug 21

PLAYMATES Sets September Date for Interim Dividend Payout

Stock News
·
Aug 21

Citi Trims CHINA OVS PPT Target Price to HK$4.5, Keeps Buy Rating on Resilience Outlook

Stock News
·
Aug 21

JPMorgan Raises J&T Express Target Price to HK$14 After Strong First-Half Results

Stock News
·
Aug 21

Lung Kee Group Announces Interim Dividend Payout Date

Stock News
·
Aug 21

中信建投看好首钢朗泽,首予“买入”评级并设定44港元目标价

Stock News
·
Aug 21

AH Share Premium Tracker | August 21 Market Close

Stock News
·
Aug 21

UBS Lifts ND Paper Target Price to HK$11.82, Reaffirms Buy on Solid Outlook

Stock News
·
Aug 21

Morgan Stanley Cuts Hysan Development Target Price to HK$19, Keeps "Market Perform" Rating

Stock News
·
Aug 21

Morgan Stanley Raises BOC Hong Kong Target Price to HK$44.2, Eyes Capital Return Plan as Key Catalyst

Stock News
·
Aug 21

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

Stock News
·
Aug 21

Morgan Stanley Raises PHARMARON Price Target to HK$35.6, Maintains Overweight Stance

Stock News
·
Aug 21